CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...